AB-MDMSBA
The following information was compiled in June 2025 and is subject to change as new research is conducted and as new information becomes available:
Description: AB-MDMSBA is a synthetic cannabinoid. AB-MDMSBA was first identified in the United States in September 2024 and since has been reported in Canada, New Zealand, and Australia.1,2,3 AB-MDMSBA was identified by our laboratory in January 2025 and confirmed after acquiring standard reference material.
Sample Source: NMS Labs — Forensic Drug Chemistry (Willow Grove, PA)
Sample Appearance: Brown powder
Pharmacology: No information is available for the activity and potency of AB-MDMSBA.
Toxicology: AB-MDMSBA has not been detected in toxicology cases to date at the CFSRE.
Drug Materials: AB-MDMSBA has been detected in one drug material to date at the CFSRE.
Demographics / Geographics: The drug material originated from Indiana. AB-MDMSBA was found alone, without the presence of other drugs or substances.
Legal Status: AB-MDMSBA is not currently scheduled in the United States.
- Class:
- Cannabinoid
- Appearance:
- Brown powder
- Formula:
- C15H23N3O4S
- MW:
- 341.4
- [M+]:
- 341
- [M+H]+:
- 342.1482
- IUPAC:
- N-(1-carbamoyl-2-methyl-propyl)-3-(dimethylsulfamoyl)-4-methyl-benzamide
- Report Date:
- June 20, 2025
